924 related articles for article (PubMed ID: 12877729)
1. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
2. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
3. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms.
McCluggage WG; Sumathi VP; Maxwell P
Histopathology; 2001 Sep; 39(3):273-8. PubMed ID: 11532038
[TBL] [Abstract][Full Text] [Related]
4. Differential Expression Patterns of GATA3 in Uterine Mesonephric and Nonmesonephric Lesions.
Roma AA; Goyal A; Yang B
Int J Gynecol Pathol; 2015 Sep; 34(5):480-6. PubMed ID: 25851711
[TBL] [Abstract][Full Text] [Related]
5. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations.
Yemelyanova A; Gown AM; Wu LS; Holmes BJ; Ronnett BM; Vang R
Int J Gynecol Pathol; 2014 Sep; 33(5):492-9. PubMed ID: 25083965
[TBL] [Abstract][Full Text] [Related]
6. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas.
McCluggage WG; Sumathi VP; McBride HA; Patterson A
Int J Gynecol Pathol; 2002 Jan; 21(1):11-5. PubMed ID: 11781517
[TBL] [Abstract][Full Text] [Related]
7. Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion.
Tambouret R; Clement PB; Young RH
Am J Surg Pathol; 2003 Aug; 27(8):1080-8. PubMed ID: 12883240
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia.
Cameron RI; Maxwell P; Jenkins D; McCluggage WG
Histopathology; 2002 Oct; 41(4):313-21. PubMed ID: 12383213
[TBL] [Abstract][Full Text] [Related]
9. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract.
Pors J; Cheng A; Leo JM; Kinloch MA; Gilks B; Hoang L
Am J Surg Pathol; 2018 Dec; 42(12):1596-1606. PubMed ID: 30148742
[TBL] [Abstract][Full Text] [Related]
11. A pre-tailored panel of antibodies in the study of cervical mesonephric remnants.
Pavlakis K; Messini I; Yiannou P; Chrissanthakis D; Papaspyrou I; Panoskaltsis T; Stathopoulos EN
Gynecol Oncol; 2010 Mar; 116(3):468-72. PubMed ID: 19913894
[TBL] [Abstract][Full Text] [Related]
12. GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract.
Howitt BE; Emori MM; Drapkin R; Gaspar C; Barletta JA; Nucci MR; McCluggage WG; Oliva E; Hirsch MS
Am J Surg Pathol; 2015 Oct; 39(10):1411-9. PubMed ID: 26135559
[TBL] [Abstract][Full Text] [Related]
13. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
14. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
Onuma K; Dabbs DJ; Bhargava R
Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
[TBL] [Abstract][Full Text] [Related]
15. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
[TBL] [Abstract][Full Text] [Related]
16. Mucinous expression in benign and neoplastic glandular lesions of the uterine cervix.
Baker AC; Eltoum I; Curry RO; Stockard CR; Manne U; Grizzle WE; Chhieng D
Arch Pathol Lab Med; 2006 Oct; 130(10):1510-5. PubMed ID: 17090193
[TBL] [Abstract][Full Text] [Related]
17. Affinity of four lectins for endocervical and endometrial non-neoplastic and neoplastic glandular epithelium.
Toda T; Sadi AM; Egawa H; Atari E; Qureshi B; Nagai Y
Histopathology; 1998 Mar; 32(3):257-63. PubMed ID: 9568512
[TBL] [Abstract][Full Text] [Related]
18. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β.
Kenny SL; McBride HA; Jamison J; McCluggage WG
Am J Surg Pathol; 2012 Jun; 36(6):799-807. PubMed ID: 22456609
[TBL] [Abstract][Full Text] [Related]
19. [Mesonephric hyperplasia in uterine cervix: report of two cases].
Zeng Y; Wu Y; Zhu X; Zhang S; Gu P; Zhu H; Qiu W; Yi X
Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):339-40. PubMed ID: 25030871
[No Abstract] [Full Text] [Related]
20. Immunohistochemical differences between mucinous and microglandular adenocarcinomas of the endometrium and benign endocervical epithelium.
Chekmareva M; Ellenson LH; Pirog EC
Int J Gynecol Pathol; 2008 Oct; 27(4):547-54. PubMed ID: 18753965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
